Why we should not stop giving aspirin to pregnant women during the COVID-19 pandemic
Ultrasound Obstet Gynecol
.
2020 Jun;55(6):841-843.
doi: 10.1002/uog.22049.
Authors
S Kwiatkowski
1
,
D Borowski
2
,
A Kajdy
3
,
L C Poon
4
,
W Rokita
5
,
M Wielgos
6
Affiliations
1
Clinical Department of Obstetrics and Gynecology, Pomeranian Medical University, Szczecin, Poland.
2
Ludwik Rydygier Collegium Medicum, Bydgoszcz, Poland.
3
Department of Reproductive Health, Centre of Postgraduate Medical Education, Warsaw, Poland.
4
Department of Obstetrics and Gynecology, The Chinese University of Hong Kong, Hong Kong SAR.
5
Faculty of Medicine and Health Sciences, Jan Kochanowski University, Kielce, Poland.
6
1st Department of Obstetrics and Gynecology, Medical University of Warsaw, Warsaw, Poland.
PMID:
32304612
PMCID:
PMC7264504
DOI:
10.1002/uog.22049
No abstract available
Publication types
Letter
Comment
MeSH terms
Aspirin
Betacoronavirus
COVID-19
Coronavirus Infections*
Female
Humans
Infant
Infant, Newborn
Pandemics
Pneumonia, Viral
Pregnancy
Pregnancy Outcome
SARS-CoV-2
Severe acute respiratory syndrome-related coronavirus*
Substances
Aspirin